Lynchburg Journal of Medical Science
Dr. Mark Archambault
Atrial fibrillation (AF) is common, with many known modifiable and nonmodifiable risk factors contributing to its increasing incidence. While pharmacologic management and invasive procedures continue to evolve as the mainstays of treatment of this disease, cardiovascular risk modification remains overlooked as a primary and adjuvant treatment strategy. This paper aims to present the clinical effects of implementing a risk factor modification strategy in the reduction of arrhythmia load.
Knechtel MA. Risk Factor Modification as a Treatment Strategy for Atrial Fibrillation. Lynchburg Journal of Medical Science. 2021; 3(3).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.